[ANN] ClinTex CTi - Faster, Cheaper, Safer Medicine : DLT in Clinical Trials

[alexgold]

They have an interesting model, so as users come to the platform and sign-up the tokens they pay with are then locked-up for 6 to 12 months according to the whitepaper. So to anyone hodl’ing this is sort of like a token burn? Do I have that right?

Yes that’s how I understood it too, except the tokens eventually will be returned to the supply pool.. but if the platform takes off then that a huge amount of tokens leaving the circulating supply??

Yea, if they accomplish this and gain market share with the pharma industry, this token value then should go through the roof with that model

So user A signs up for a licence, the pay in CLX, the CLX is then locked into their wallet on CTi for 6 -12 months. When the licence expires, the user gets their CLX back?

[1714821657]

1714821657

[1714821657]

1714821657

[1714821657]

1714821657

[1714821657]

1714821657

[EggieR]

They have an interesting model, so as users come to the platform and sign-up the tokens they pay with are then locked-up for 6 to 12 months according to the whitepaper. So to anyone hodl’ing this is sort of like a token burn? Do I have that right?

Yes that’s how I understood it too, except the tokens eventually will be returned to the supply pool.. but if the platform takes off then that a huge amount of tokens leaving the circulating supply??

Yea, if they accomplish this and gain market share with the pharma industry, this token value then should go through the roof with that model

So user A signs up for a licence, the pay in CLX, the CLX is then locked into their wallet on CTi for 6 -12 months. When the licence expires, the user gets their CLX back?

I think they can use the staked balance to pay for data on the platform too

[Almostdone1]

They have an interesting model, so as users come to the platform and sign-up the tokens they pay with are then locked-up for 6 to 12 months according to the whitepaper. So to anyone hodl’ing this is sort of like a token burn? Do I have that right?

Yes that’s how I understood it too, except the tokens eventually will be returned to the supply pool.. but if the platform takes off then that a huge amount of tokens leaving the circulating supply??

Yea, if they accomplish this and gain market share with the pharma industry, this token value then should go through the roof with that model

So user A signs up for a licence, the pay in CLX, the CLX is then locked into their wallet on CTi for 6 -12 months. When the licence expires, the user gets their CLX back?

I think they can use the staked balance to pay for data on the platform too

Well they have as much as chance as any ICO project I’ve ever seen. More actually, this is a real and valid use case for blockchain and thankfully they are not trying to do everything on-chain either, as a business I could see this one taking off

[osipov_oksnik]

I see they are accepting BNB in the ICO, looks like this will be getting listed on Binance?

[Tupakk]

I see they are accepting BNB in the ICO, looks like this will be getting listed on Binance?

And also the team is based in Malta too where Binance is, I’d say chances are extremely high that this one gets listed

[|Konstantin07]

I see they are accepting BNB in the ICO, looks like this will be getting listed on Binance?

And also the team is based in Malta too where Binance is, I’d say chances are extremely high that this one gets listed

The hardcap is very reasonable for what they are planning to achieve, finally realistic caps are becoming a thing

[Slava_Osipov]

I see they are accepting BNB in the ICO, looks like this will be getting listed on Binance?

And also the team is based in Malta too where Binance is, I’d say chances are extremely high that this one gets listed

The hardcap is very reasonable for what they are planning to achieve, finally realistic caps are becoming a thing

It is pretty ambitious trying to tackle big pharma, such an absolutely enormous market and that is the sort of budget I’d expect to see for a project disrupting it

[vladimir54]

I work in clinical trials and I can tell you the actual tool looks amazing. In the industry people have been saying for a long time that the correct predictive analytics in clinical trials will allow us to calculate if the medicine is gonna be successful even before the trial is over!

From the whitepaper, what’s different about this tool is that all the data from all the different clinical trial sources will now all be in one place. We could do good things when all this data is together. No one else is doing prediction on clinical trial data as far as I know – the market for this tool is huge

[globus_mipa]

I work in clinical trials and I can tell you the actual tool looks amazing. In the industry people have been saying for a long time that the correct predictive analytics in clinical trials will allow us to calculate if the medicine is gonna be successful even before the trial is over!

From the whitepaper, what’s different about this tool is that all the data from all the different clinical trial sources will now all be in one place. We could do good things when all this data is together. No one else is doing prediction on clinical trial data as far as I know – the market for this tool is huge

So do I, and the FDA chief has come out to signal he is supporting this approach too - the pharmaceutical companies like the one I work for are going to look to software like this - see https://www.mobihealthnews.com/content/fda-chief-sees-big-things-ai-healthcare

[kurko2017]

I work in clinical trials and I can tell you the actual tool looks amazing. In the industry people have been saying for a long time that the correct predictive analytics in clinical trials will allow us to calculate if the medicine is gonna be successful even before the trial is over!

From the whitepaper, what’s different about this tool is that all the data from all the different clinical trial sources will now all be in one place. We could do good things when all this data is together. No one else is doing prediction on clinical trial data as far as I know – the market for this tool is huge

So do I, and the FDA chief has come out to signal he is supporting this approach too - the pharmaceutical companies like the one I work for are going to look to software like this - see https://www.mobihealthnews.com/content/fda-chief-sees-big-things-ai-healthcare

It makes sense, there are tens of thousands of clinical trials and hundreds of thousands of patients every year who could benefit from something like this CTi platform

[DutchTranslator]

I see they are accepting BNB in the ICO, looks like this will be getting listed on Binance?

Hi there! The team doesn't have an official partnership with Binance. However, as supporters of Binance’s contribution to the cryptocurrency space, they are happy to endorse BNB and the Binance eco-system by accepting BNB in during the TGE, along with BTC and ETH

[DimLeg]

Very interested in this platform, my Dad has got motor neurone disease (ALS) and he was waiting for FDA approval for Radicava. Eventually it happened, but now the insurance company won’t cover him because its too expensive. This seems to be proposing a solution or at least a helping hand for such an obvious problem in the world

[oa17]

I work in clinical trials and I can tell you the actual tool looks amazing. In the industry people have been saying for a long time that the correct predictive analytics in clinical trials will allow us to calculate if the medicine is gonna be successful even before the trial is over!

From the whitepaper, what’s different about this tool is that all the data from all the different clinical trial sources will now all be in one place. We could do good things when all this data is together. No one else is doing prediction on clinical trial data as far as I know – the market for this tool is huge

So do I, and the FDA chief has come out to signal he is supporting this approach too - the pharmaceutical companies like the one I work for are going to look to software like this - see https://www.mobihealthnews.com/content/fda-chief-sees-big-things-ai-healthcare

It makes sense, there are tens of thousands of clinical trials and hundreds of thousands of patients every year who could benefit from something like this CTi platform

Indeed, ClinTex will be collecting this data by using IoT too and then everything will be analyzed using data mining and artificial intelligence. This data will be recorded on the blockchain from the moment of capturing it all the way to analyzing it.

Make sure that join ClinTex on Telegram and Reddit guys

Telegram group: https://t.me/ClinTexCTi

Telegram channel: https://t.me/ClinTexCTiNews

Reddit: https://www.reddit.com/r/ClinTexCTi

[jannamaile]

Very interested in this platform, my Dad has got motor neurone disease (ALS) and he was waiting for FDA approval for Radicava. Eventually it happened, but now the insurance company won’t cover him because its too expensive. This seems to be proposing a solution or at least a helping hand for such an obvious problem in the world

Big time, the whole set up with the price of medical treatment is extortion!

[Vojdel]

The token economics here look pretty good, only 10% went to private sale so the public round buyers hopefully wont be getting dumped on by big funds

[dimadmitriev]

The token economics here look pretty good, only 10% went to private sale so the public round buyers hopefully wont be getting dumped on by big funds

That really pisses me off lately when you see a good project but then its only 2% or 5% for sale in the public round, you just know you are getting fucked over compared to the earlier rounds

[LilBoby]

The token economics here look pretty good, only 10% went to private sale so the public round buyers hopefully wont be getting dumped on by big funds

That really pisses me off lately when you see a good project but then its only 2% or 5% for sale in the public round, you just know you are getting fucked over compared to the earlier rounds

Exactly, and it’s a trend now to give the big boys big bonuses so this is pretty good – 50% going to public and presale with 20% and that’s it. I’m gonna try get in on the presale.

[Vladrak]

The token economics here look pretty good, only 10% went to private sale so the public round buyers hopefully wont be getting dumped on by big funds

That really pisses me off lately when you see a good project but then its only 2% or 5% for sale in the public round, you just know you are getting fucked over compared to the earlier rounds

Exactly, and it’s a trend now to give the big boys big bonuses so this is pretty good – 50% going to public and presale with 20% and that’s it. I’m gonna try get in on the presale.

When is the presale?

[oa17]

Hello there, there are no confirmed dates for the token sale yet. The Pre-Sale will take place in Q4, 2018. The exact dates are to be announced. Just join the announcements channel then you will get updated once everything is confirmed 😊
https://t.me/ClinTexCTiNews

[Ivakimos]

The token economics here look pretty good, only 10% went to private sale so the public round buyers hopefully wont be getting dumped on by big funds

That really pisses me off lately when you see a good project but then its only 2% or 5% for sale in the public round, you just know you are getting fucked over compared to the earlier rounds

Exactly, and it’s a trend now to give the big boys big bonuses so this is pretty good – 50% going to public and presale with 20% and that’s it. I’m gonna try get in on the presale.

When is the presale?

Next month I think